• Explore /
  • Poster
  • / Pembrolizumab (pembro) versus standard of care chemotherapy (chemo) in patients with advanced gastric or gastroesophageal junction adenocarcinoma: Asian subgroup analysis of KEYNOTE-062.

Pembrolizumab (pembro) versus standard of care chemotherapy (chemo) in patients with advanced gastric or gastroesophageal junction adenocarcinoma: Asian subgroup analysis of KEYNOTE-062.

Abstract Video & Slides Poster

Authors

null

Hironaga Satake

Kobe City Medical Center General Hospital, Kobe City, Japan

Hironaga Satake , Keun Wook Lee , Hyun Cheol Chung , Jeeyun Lee , Kensei Yamaguchi , Jen-Shi Chen , Takaki Yoshikawa , Kenji Amagai , Kun-Huei Yeh , Masahiro Goto , Yee Chao , Ka-On Lam , Shi Rong Han , Shinichi Shiratori , Sukrut Shah , Kohei Shitara

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2020 ASCO Virtual Scientific Program

Session Type

Poster Session

Session Title

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Track

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Sub Track

Esophageal or Gastric Cancer

Clinical Trial Registration Number

NCT02494583

Citation

J Clin Oncol 38: 2020 (suppl; abstr 4523)

DOI

10.1200/JCO.2020.38.15_suppl.4523

Abstract #

4523

Poster Bd #

131

Abstract Disclosures

Similar Posters

First Author: Zev A. Wainberg

First Author: Yelena Y. Janjigian

First Author: Joseph Chao

First Author: Zev A. Wainberg